×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABT – abbott laboratories (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
11:39 am
abt
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement [Yahoo! Finance]
Low
Report
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement [Yahoo! Finance]
12/4
11:00 am
abt
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
Low
Report
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
12/2
11:41 pm
abt
7 deaths linked to faulty blood glucose monitors as FDA issues safety warning [FOX Business Network]
Low
Report
7 deaths linked to faulty blood glucose monitors as FDA issues safety warning [FOX Business Network]
11/29
01:17 pm
abt
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition [Yahoo! Finance]
Low
Report
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition [Yahoo! Finance]
11/28
03:32 pm
abt
How Analyst Views on Abbott Are Evolving as Its Growth Story Faces New Twists [Yahoo! Finance]
Neutral
Report
How Analyst Views on Abbott Are Evolving as Its Growth Story Faces New Twists [Yahoo! Finance]
11/26
10:06 am
abt
Robert F. Kennedy, Jr. Escalates His War On Vaccines [Forbes]
Low
Report
Robert F. Kennedy, Jr. Escalates His War On Vaccines [Forbes]
11/26
07:46 am
abt
Is Abbott Laboratories Stock Underperforming the S&P 500? [Yahoo! Finance]
Low
Report
Is Abbott Laboratories Stock Underperforming the S&P 500? [Yahoo! Finance]
11/26
07:12 am
abt
Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue [Yahoo! Finance]
Low
Report
Pediatric Interventional Cardiology Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
11:02 am
abt
Form SCHEDULE 13G/A ABBOTT LABORATORIES Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A ABBOTT LABORATORIES Filed by: VANGUARD GROUP INC
11/25
04:18 pm
abt
Form 4 ABBOTT LABORATORIES For: Nov 25 Filed by: Shroff Eric
Low
Report
Form 4 ABBOTT LABORATORIES For: Nov 25 Filed by: Shroff Eric
11/25
04:09 pm
abt
Form 144 ABBOTT LABORATORIES Filed by: Shroff Eric
Low
Report
Form 144 ABBOTT LABORATORIES Filed by: Shroff Eric
11/21
04:06 pm
abt
Form 8-K ABBOTT LABORATORIES For: Nov 18
Low
Report
Form 8-K ABBOTT LABORATORIES For: Nov 18
11/20
07:38 am
abt
Form 8-K ABBOTT LABORATORIES For: Nov 19
Low
Report
Form 8-K ABBOTT LABORATORIES For: Nov 19
10/29
04:23 pm
abt
Form 10-Q ABBOTT LABORATORIES For: Sep 30
Low
Report
Form 10-Q ABBOTT LABORATORIES For: Sep 30
10/15
07:34 am
abt
Form 8-K ABBOTT LABORATORIES For: Oct 15
Low
Report
Form 8-K ABBOTT LABORATORIES For: Oct 15
10/2
05:03 pm
abt
Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Stratton John G
Low
Report
Form 4 ABBOTT LABORATORIES For: Sep 30 Filed by: Stratton John G
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Abbott Labs Is Sliding Closer To Attractive Territory [Seeking Alpha]
10.0%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
TOP News Decliners
3/18
Associated Press: Cancer and heart surgeries now delayed as coronavirus alters care [MarketWatch]
-10.8%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: